telehealth glp-1 prescription california FDA takes aim at companies for promoting unofficial weight loss drug dupes GLP-1 Telehealth West Coast: California,

The study, published in the American Journal of Gastroenterology in June, found no substantial evidence to recommend significantly delaying procedures based on gastric emptying tests

Most individuals experience maximum appetite effects within 4-8 weeks of reaching therapeutic doses

Peer review Peer review information Nature Reviews Cardiology thanks Stephen Bain and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

The FDA has issued multiple rounds of warning letters to telehealth companies for marketing claims about compounded GLP-1 products that, in the agency's view, implied equivalence to FDA-approved medications or obscured the identity of the actual compounder

PubMedPMC 86